Covered recipient · General Payments record
SARAH ANN-LOUISE KOCH
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2022–2024
$2,086.71
- Reported across 81 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $827.67 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $275.36 | 14 |
| Inari Medical, Inc. | $131.41 | 1 |
| UCB, Inc. | $71.63 | 2 |
| Celgene Corporation | $50.63 | 2 |
| Alexion Pharmaceuticals, Inc. | $37.89 | 2 |
| Teva Pharmaceuticals USA, Inc. | $34.48 | 1 |
| Lundbeck LLC | $33.38 | 1 |
| SK Life Science, Inc. | $28.52 | 1 |
| PFIZER INC. | $26.19 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.49 | 1 |
| EISAI INC. | $24.44 | 1 |
| Neurelis, Inc. | $24.41 | 1 |
| ACADIA Pharmaceuticals Inc | $23.48 | 1 |
| Lilly USA, LLC | $21.01 | 1 |
| LeMaitre Vascular, Inc. | $20.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.37 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104091330 | CMS |
| ABBVIE INC. | $14.48 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104091332 | CMS |
| ABBVIE INC. | $14.21 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104091334 | CMS |
| ABBVIE INC. | $10.00 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104091336 | CMS |
| ABBVIE INC. | $25.27 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104091338 | CMS |
| ABBVIE INC. | $34.13 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104091340 | CMS |
| ABBVIE INC. | $15.05 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104091342 | CMS |
| ABBVIE INC. | $9.35 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104091344 | CMS |
| ABBVIE INC. | $23.15 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104091346 | CMS |
| ABBVIE INC. | $16.53 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104091348 | CMS |
| ABBVIE INC. | $7.31 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104091350 | CMS |
| ABBVIE INC. | $29.67 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104091352 | CMS |
| ABBVIE INC. | $13.55 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104091354 | CMS |
| ABBVIE INC. | $31.29 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104091356 | CMS |
| ACADIA Pharmaceuticals Inc | $23.48 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147980976 | CMS |
| Alexion Pharmaceuticals, Inc. | $19.63 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093891868 | CMS |
| Alexion Pharmaceuticals, Inc. | $18.26 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094031240 | CMS |
| Celgene Corporation | $24.23 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101129860 | CMS |
| Celgene Corporation | $26.40 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101129886 | CMS |
| Eisai Inc. | $24.44 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110780064 | CMS |
| Inari Medical, Inc. | $131.41 | 11/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140122832 | CMS |
| LeMaitre Vascular, Inc. | $20.35 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138056080 | CMS |
| Lilly USA, LLC | $21.01 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135417565 | CMS |
| Lundbeck LLC | $33.38 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145934940 | CMS |
| Neurelis, Inc. | $24.41 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145645557 | CMS |
| Novartis Pharmaceuticals Corporation | $24.49 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087145812 | CMS |
| PFIZER INC. | $26.19 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131796076 | CMS |
| SK Life Science, Inc. | $28.52 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154145778 | CMS |
| Teva Pharmaceuticals USA, Inc. | $34.48 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151710625 | CMS |
| UCB, Inc. | $39.31 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143286973 | CMS |
| UCB, Inc. | $32.32 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143286977 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.